Prognostic and Therapeutic Impact of RPN2-mediated Tumor Malignancy in Non-Small-Cell Lung Cancer

Oncotarget - United States
doi 10.18632/oncotarget.2793
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

RPN2-mediated Glycosylation of Tetraspanin CD63 Regulates Breast Cancer Cell Malignancy

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2014English

Adverse Prognostic Impact of TGFB1 T869C Polymorphism in Non-Small-Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2017English

Prognostic Impact of Serum Transthyretin in Patients With Non‑small Cell Lung Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2019English

Tumor Evolution in Non-Small-Cell Lung Cancer

ESMO Open
Cancer ResearchOncology
2018English

Prognostic Significance of CD276 in Non-Small Cell Lung Cancer

Open Medicine (Poland)
Medicine
2019English

Comparison of Primary Tumor SUVmax Between Small Cell Lung Cancer and Non-Small Cell Lung Cancer

Current Trends in Clinical & Medical Imaging
2019English

Prognostic Impact of Radiation Therapy to the Primary Tumor in Patients With Non-Small Cell Lung Cancer and Oligometastasis at Diagnosis

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2012English

Prognostic Gene Signatures for Non-Small-Cell Lung Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

Prognostic Significance of FoxM1 Expression in Non-Small Cell Lung Cancer

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy